GS
RMD icon

GTS Securities’s ResMed RMD Stock Holding History

GTS Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,000
Closed -$6.59M – 3456
2024
Q3 		$6.59M Sell
27,000
-2,700
-9% -$603K 0.01% 722
2024
Q2 		$5.69M Sell
29,700
-6,300
-18% -$1.28M 0.01% 793
2024
Q1 		$7.13M Buy
36,000
+28,400
+374% +$5.2M 0.01% 665
2023
Q4 		$1.31M Sell
7,600
-1,800
-19% -$277K ﹤0.01% 1965
2023
Q3 		$1.39M Buy
+9,400
New +$1.7M ﹤0.01% 1772

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GTS Securities's RMD Position: Q2 2026 in Review

GTS Securities increased its ResMed (RMD) stake by 659% in Q2 2026, buying an estimated $1.89M and bringing the position to 10,514 shares worth $2.05M. The position accounts for 0.04% of the portfolio, ranked #248.

GTS Securities first reported a position in RMD in Q4 2023 and has held it in 9 quarters since. The position peaked at $3.84M in Q4 2023. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • GTS Securities held 10,514 shares of ResMed worth $2.05M as of Q2 2026.
  • GTS Securities bought 9,129 ResMed shares in Q2 2026, an estimated $1.89M.
  • ResMed made up 0.04% of GTS Securities's portfolio in Q2 2026, its #248 holding.
  • GTS Securities first reported a position in ResMed in Q4 2023 and has held it in 9 quarters since.
  • GTS Securities's ResMed position peaked at $3.84M in Q4 2023.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.